Pro- and antioxidant blood system in patients with rheumatoid arthritis and systemic lupus erythematosus

Terapevticheskii Arkhiv

Volumn 78, Issue 6, 2006, Pages 10-14

  Vipartene, D ^a   Yasyulevichute, L ^a   Butkene, B ^a   Valyukene, K ^a   Keturkene, A ^a   Redaitene, E ^a  

^a NONE

Author keywords

Antioxidant enzymes; Malonic dialdehyde; Nitric oxide; Rheumatoid arthritis; Systemic lupus erythematosus; Zinc

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; ENZYMOLOGY; FEMALE; HOSPITALIZATION; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREVALENCE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE;

EID: 33746827707     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tep. apx. 1994; 66 (5): 82-87.
2. Jasin H. E. Mechanism of joint destruction in rheumatoid arthritis. J. Orthop. Sci. 2000; 5: 178-181.
3. Nishida K., Doi T., Inoul H. The role of nitric oxide in arthritic joints: a therapeutic target? Mod. Rheumatol. 2000; 10: 63-67.
4. Belmont H. M., Levartovsky D., Goel A. et al. Increased nitric oxide production by the up-regulation of inducible nitric oxide in vascular endothelium from patients with systemic lupus erythematosus. Arthr. and Rheum. 1997; 40: 1810-1820.
5. Tep. apx. 2004; 5: 19-22.
6. Cimen M. Y., Cimen O. B., Kacmaz M. et al. Oxidant/antioxidant status of the erythrocytes from patients of rheumatoid arthritis. Clin. Rheumatol. 2000; 19 (4): 275-277.
7. Ozturk H. S., Cimen M. Y. B., Cimen O. B. et al. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol. Int. 1999; 19: 35-37.
8. Taysi S., Polat F., Gul M. et al. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol. Int. 2002; 21 (5): 200-204.
9. Krupovnickiené A., Vipartiené D., Valiukiené K. Study of malondialdehyde content, total antioxidant and catalase activities in rheumatic diseases. Acta Med. Lithuan. 1999; 6 (4): 279-282.
10. Tep. apx. 1994; 4: 57-62.
11. Hassan M. Q., Hadi R. A., Al-Rawi Z. S. et al. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J. Appl. Toxicol. 2001; 21 (1): 69-73.
12. Evans P., Halliwell B. Micronutrients: oxidant/antioxidant status. Br. J. Nutr. 2001; 85 (2): 67-84.
13. Polidori M. C., Stahl W., Eichler O. et al. Profiles of antioxidants in human plasma. Free Radic. Biol. Med. 2001; 30 (5): 456-462.
14. Arnett F. C., Edworthy S. M., Bloch D. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr. and Rheum. 1988; 31: 315-324.
15. Tep. apx. 2002; 5: 57-60.
16. Tan E. M., Cohen A. S., Fries J. F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr. and Rheum. 1982; 25: 1271-1277.
17. Bombardier C., Gladman D. D., Urowitz M. B. et al. Committee on Prognosis Studies in SLE: Derivation of SLEDAI: a disease activity index for lupus patients. Arthr. and Rheum. 1992; 35: 630-640.
18. de Blas O. J., Rodriguez R. S., Mendez J. H. Determination of zinc in serum, blood and ultrafiltrate fluid from patients on hemofiltration by graphite furnace/atomic absorption spectroscopy or flow injection analysis/atomic absorption spectroscopy. J. Assoic. Offic. Analyt. Chem. 1994; 77: 722-727.
19. Wanchu A., Khullar M., Deodhar S. D. et al. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol. Int. 1998; 18: 41-43.
20. Farrell A. J., Blake D. R., Palmer R. M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 1992; 51: 1219-1222.
21. Gambhir J. K., Lali P., Jain A. K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin. Biochem. 1997; 30 (4): 351-355.
22. Zago M. P., Oteiza P. I. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic. Biol. Med. 2001; 31 (2): 266-274.
23. Onur O., Akinci A. S., Akbiyik F., Unsal I. Elevated levels of nitrate in rheumatoid arthritis. Rheumatol. Int. 2001; 20: 154-158.
24. Kamanli A., Naziroglu M., Aydilek N., Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem. Funct. 2004; 22 (1): 53-57.